A recent study published in PubMed highlights the use of fresh frozen plasma as a functional replacement therapy for early infantile ApoC-II deficiency. This case series provides molecular confirmation of the therapy's effectiveness in managing this rare condition.
fresh frozen plasma as functional replacement therapy in early infantile apoc ii deficiency a molecularly confirmed case series
Original title: “Fresh frozen plasma as functional replacement therapy in early infantile ApoC-II deficiency: a molecularly confirmed case series.”